Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate effects on the developing brain in male ADHD patients
NL-OMON39033Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (4 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: phMRI dopaminergic response, DTI structural measures and 2 more. Started May 2011; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON39033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39033.